LivaNova (LIVN) Net Income Growth (1y) (2015 - 2026)
LivaNova (LIVN) Net Income Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 75.09% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 12.92% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 300.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300.03% |
| Mar 31, 2026 | 107.07% |
| Dec 31, 2025 | -44.69% |
| Sep 30, 2025 | -18.59% |
| Jun 30, 2025 | 66.05% |
| Mar 31, 2025 | -680.83% |
| Dec 31, 2024 | 241.72% |
| Sep 30, 2024 | 551.77% |
| Jun 30, 2024 | 1,283.09% |
| Mar 31, 2024 | -666.68% |
| Dec 31, 2023 | 867.81% |
| Sep 30, 2023 | 93.22% |
| Jun 30, 2023 | -92.82% |
| Mar 31, 2023 | 143.96% |
| Dec 31, 2020 | -366.31% |
| Dec 31, 2019 | 118.30% |
| Jun 30, 2019 | 103.99% |
| Dec 31, 2018 | 98.73% |
| Sep 30, 2018 | -210.92% |
| Jun 30, 2018 | -345.30% |